ENTITY
HeMo Bioengineering

HeMo Bioengineering (HMB HK)

4
Analysis
Health Care • Hong Kong

bullish•HeMo Bioengineering
•02 Feb 2022 09:14

Pre-IPO HeMo Bioengineering - Insights on Industry, Business and Concerns

We analyzed the industry characteristics, the business and competitive landscape of HeMo. The centralized procurement, commercialization...

Logo
399 Views
Share
•30 Dec 2021 09:15

Concerns and Outlook on China Neuro-Interventional Industry

The insight analyzed ChinaĀ neuro-interventionalĀ industry including the reason of cool-down in primary market, theĀ product homogenization, fierce...

Logo
608 Views
Share
bullish•Li Ning
•31 Oct 2021 09:56

ECM Weekly (31st October 2021) - Patym, PolicyBazaar, Nykaa, HeMo, Clover Bio, UJU, Airdoc, Mitratel

Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.

Logo
326 Views
Share
bearish•HeMo Bioengineering
•28 Oct 2021 14:47

HeMo Bioengineering (ē¦¾ęœØē”Ÿē‰©å·„ēØ‹) Pre-IPO: Signs of Lacking Innovation

We look at HeMo Bioengineering's main products. We are not convinced that its aspiration catheter products are innovative and competitive.

Logo
614 Views
Share
No more insights
x